Bard Associates’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-66,770
| Closed | -$154K | – | 195 |
|
|
2022
Q3 | $154K | Sell |
66,770
-150
| -0.2% | -$346 | 0.07% | 158 |
|
|
2022
Q2 | $207K | Hold |
66,920
| – | – | 0.09% | 155 |
|
|
2022
Q1 | $243K | Buy |
66,920
+5,000
| +8% | +$18.2K | 0.09% | 155 |
|
|
2021
Q4 | $240K | Buy |
61,920
+7,100
| +13% | +$27.5K | 0.08% | 159 |
|
|
2021
Q3 | $346K | Buy |
54,820
+1,080
| +2% | +$6.82K | 0.12% | 141 |
|
|
2021
Q2 | $429K | Buy |
53,740
+15,440
| +40% | +$123K | 0.14% | 129 |
|
|
2021
Q1 | $417K | Buy |
+38,300
| New | +$417K | 0.15% | 123 |
|